ICFP News & Insights

Medicines360: Creating Equitable Access

Nov 11, 2022

GUEST COLUMN:

Medicines360

by Tina Raine-Bennett

Our Mission is to catalyze equitable access to medicines and devices through product development, policy advocacy, and collaboration with global and U.S. partners

We are expanding access to our IUD in Africa, South and Southeast Asia, Central America, and the Caribbean, under the brand AvibelaTM

AVIBELA is manufactured in Belgium and supplied to global and local partners by Medicines360

Local partners lead distribution, training, and service delivery
AVIBELA is available at a subsidized access price for all units ordered through international procurement group catalogs or on behalf of eligible public sector programs.

For questions or to learn more about Avibela and about the new products and partnerships in our pipeline, visit Avibela.com, Medicines360.org, or email globalaccess@medicines360.org

 

Learn more about the Medicines360:

Explore More

ICFP 2025 Sets New Record for Abstract Submissions

ICFP 2025 Sets New Record for Abstract Submissions

You Asked, We’re Extending—Submit by April 22

You Asked, We’re Extending—Submit by April 22

#ICFP2025 Abstract Countdown: Why we need YOUR voice

#ICFP2025 Abstract Countdown: Why we need YOUR voice

No results found.
ICFP 2025

Key Dates & Deadlines

  • Early Registration: 30 May–31 July 2025
  • Abstract Acceptance Notifications: 20 June 2025
  • Travel Award Applications Open: 20–30 June 2025
  • Travel Award Notifications: 14 July 2025
  • Standard Registration: 1 August–30 September 2025
  • Last Day for Group Registration: 15 October 2025
  • Late Registration: 1–27 October 2025
  • Pre-conferences, Site Visits, Side Events: 1–3 November 2025
  • ICFP 2025: 3–6 November 2025